γλώσσες
Σελίδες
Νομικός
Explore all categories to find your favorite topic
Immunotherapies currently in development for the treatment of type 1 diabetes Ian C Davis, Jacqueline Randell & Stephen N Davis Expert Opinion on Investigational Drugs,…
When your child is too sweet By Dr Liaw Siew Ching * IDDM/ Type I DM Introduction Physiology of diabetes in β cell failure in type 1 DM DKA Long term management of diabetes…
Diabetes Mellitus Type II Beta Cell Failure in DM T2 signaling pathways implicated in β-cell failure Wnt Signaling Pathway Controls organismal growth and differentiation…
The Dapagliflozin Effects on Cardiovascular Events (DECLARE) Study ClinicalTrials.gov ID: NCT01730534SGLT2 12 – 20 Zuckerwürfeln Type 2 diabetes = Protection against
DIABETES MANAGEMENT Naushira Pandya, MD, CMD, FACP Professor and Chair, Department of Geriatrics Director, Geriatrics Education Center Nova Southeastern University Kiran…
1.Insulins in Type 2 DiabetesMellitus Dr. Sharat S. Kolke MD, DNB2. WhenWhyHow? 3. Serum Insulin levelEndogenous insulin Time (hrs)Dynamic nature of normal endogenous insulin…
Diagnosing Diabetes Mellitus in Adults: Type 1, LADA, Type 2: Rationale and Implications of a β-Cell- Centric Classification of Diabetes Stanley Schwartz MD, FACE, FACP…
1068 wwwthelancetcom Vol 383 March 22 2014 Review Pathophysiology and treatment of type 2 diabetes: perspectives on the past present and future Steven E Kahn Mark E Cooper…
Diagnosing Diabetes Mellitus in Adults: Type 1, LADA, Type 2: Rationale and Implications of a β-Cell- Centric Classification of Diabetes Stanley Schwartz MD, FACE, FACP…
Advancing Type 2 Diabetes Care With Modern Insulins Advancing Type 2 Diabetes Care With Modern Insulins Goals Type 2 Diabetes Is Progressive Most Patients Are Not Achieving…
1 Pathophysiological mechanism of bone loss in type 2 diabetes involves inverse 1 regulation of osteoblast function by PPARγγγγ coactivator-1α and skeletal muscle 2…
Oral hypoglycemic agents in type 2 diabetes Type 2 diabetes is a disease of progressive β-cell dysfunction in presence of insulin resistance, leading to gradual loss of…
Slide 1 Renal Cancer Immunotherapy Walter Stadler 1 2 Renal cancer natural history 2 Manola J et al. Clin Cancer Res 2011;17:5443-5450 International prognostic model β SE…
1.GLICLAZIDE MR IN THEMANAGEMENT OF TYPE 2 DMDr. Nazma AkhtarResident phase BDepartment of EndocrinologyBSMMU2. 3/28/2013 3 3. 3/28/2013 4 4. SULFONYLUREA: OAD agentMode…
Slide 1 DIABETES TYPE 2 Humaira Fareed Hassan April 21 st, 2009 Slide 2 TODAY, I WILL DISCUSS … Definition What is insulin? Types of Diabetes What sets Type 1 & Type…
Treatment of type 1 diabetes via α-cell insulin production Bertozzi Alessia Buccioli Lucia Tosato Federica Gene Therapy Professor Isabella Saggio A.Y. 20182019 Background…
DOI: 10.1530JOE-16-0021 Jo u rn al o f En d o cr in o lo g y http:joe.endocrinology-journals.org 2016 Society for Endocrinology Printed in Great Britain Published by Bioscientifica…
The Journal of Clinical Investigation R E V I E W 1 jciorg Volume 127 Number 8 August 2017 Introduction Type 1 diabetes T1D is a chronic autoimmune disease resulting in severe…
Type 2 Diabetes – 2010 Robert J. Rushakoff, MD Professor of Medicine University of California, San Francisco [email protected] Hyperglycemia β ⇑⇑⇑⇑ hepatic…
Slide 1Drug - treatment of Type 2 diabetes mellitus Oral antidiabetics as. MUDr. Pavlína Piťhová Slide 2 - 20 -10 0 10 20 30 yars Manifestation DM 7mmol/l Plasma glucose…